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MaBACKGROUND The associations between dietary saturated fats and the risk of coronary heart disease (CHD) remain
controversial, but few studies have compared saturated with unsaturated fats and sources of carbohydrates in relation to
CHD risk.
OBJECTIVES This study sought to investigate associations of saturated fats compared with unsaturated fats and
different sources of carbohydrates in relation to CHD risk.
METHODS We followed 84,628 women (Nurses’ Health Study, 1980 to 2010), and 42,908 men (Health Professionals
Follow-up Study, 1986 to 2010) who were free of diabetes, cardiovascular disease, and cancer at baseline. Diet was
assessed by a semiquantitative food frequency questionnaire every 4 years.
RESULTS During 24 to 30 years of follow-up, we documented 7,667 incident cases of CHD. Higher intakes of polyun-
saturated fatty acids (PUFAs) and carbohydrates from whole grains were signiﬁcantly associated with a lower risk of CHD
comparing the highest with lowest quintile for PUFAs (hazard ratio [HR]: 0.80, 95% conﬁdence interval [CI]: 0.73 to 0.88; p
trend <0.0001) and for carbohydrates from whole grains (HR: 0.90, 95% CI: 0.83 to 0.98; p trend ¼ 0.003). In contrast,
carbohydrates from reﬁned starches/added sugars were positively associated with a risk of CHD (HR: 1.10, 95% CI: 1.00 to
1.21; p trend ¼ 0.04). Replacing 5% of energy intake from saturated fats with equivalent energy intake from PUFAs,
monounsaturated fatty acids, or carbohydrates from whole grains was associated with a 25%, 15%, and 9% lower risk of
CHD, respectively (PUFAs, HR: 0.75, 95% CI: 0.67 to 0.84; p < 0.0001; monounsaturated fatty acids, HR: 0.85, 95% CI:
0.74 to 0.97; p ¼ 0.02; carbohydrates from whole grains, HR: 0.91, 95% CI: 0.85 to 0.98; p ¼ 0.01). Replacing saturated
fats with carbohydrates from reﬁned starches/added sugars was not signiﬁcantly associated with CHD risk (p > 0.10).
CONCLUSIONS Our ﬁndings indicate that unsaturated fats, especially PUFAs, and/or high-quality carbohydrates can be
used to replace saturated fats to reduce CHD risk. (J Am Coll Cardiol 2015;66:1538–48) © 2015 by the American College
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1539AB BR E V I A T I O N S
AND ACRONYM S
CHD = coronary heart disease
CI = conﬁdence interval
FFQ = food frequency
questionnaire
GI = glycemic index
HR = hazard ratio
MI = myocardial infarction
MUFA = monounsaturated
fatty acid
PUFA = polyunsaturated fatty
acid
SFA = saturated fatty acidA recent systematic review and meta-analysisreported no signiﬁcant association betweenthe consumption of saturated fatty acids
(SFAs) and the risk of coronary heart disease (CHD)
(1), but the study failed to specify the replacement
macronutrient for saturated fat. Another meta-
analysis observed that substituting SFAs with overall
carbohydrates was not associated with the risk of CHD
(2). Consistent with this analysis, a low-carbohydrate
diet score (a higher score being indicative of higher
protein and fat intake and lower intake of carbohy-
drates) was not associated with an increased CHD
risk in women (3). None of these studies, however,
discriminated between different sources of dietary
carbohydrates.SEE PAGE 1549Carbohydrates, traditionally classiﬁed as simple
versus complex, depending on the number of
chained sugar moieties, are also frequently classiﬁed
according to their effect on blood sugar levels, as
quantiﬁed by the glycemic index (GI). Carbohydrate
classiﬁcation by the GI has been shown to be more
strongly associated with cardiometabolic disease
than total carbohydrates. For example, whereas no
association was observed between overall carbohy-
drate intake and the risk of CHD (4,5), diets with a
low GI were associated with a lower risk of CHD (4,5)
and type 2 diabetes (6) compared with high-GI diets.
Therefore, it is not surprising that null associations
between SFAs and coronary risk were observed in
studies that did not distinguish between the quality
of carbohydrates that were being substituted for
SFAs.
Only a few studies have considered the quality of
the carbohydrates substituting for SFAs in CHD (7,8).
One study (7) observed that substituting SFAs with
carbohydrates was associated with a nonsigniﬁcantly
lower risk of myocardial infarction (MI) among par-
ticipants who consumed a low-GI diet, but with a
signiﬁcantly increased risk among participants who
consumed a high-GI diet. However, this association
was not replicated in another study (8). To address
uncertainties about the associations between dietary
fats, carbohydrate quality, and CHD, we aimed to
investigate the predicted effects of isocaloric sub-
stitutions of carbohydrates for fats, with an a priori
hypothesis that the effects of different types of fats on
the risk of CHD depend on the carbohydrate quality of
the replacement. Two well-established cohorts of U.S.
women and men: the NHS (Nurses’ Health Study) (9)
and the HPFS (Health Professionals Follow-up Study)
(10) were the basis for this study. This analysis may
have important public health implications for guidingpeople toward healthy dietary choices as they
work to reduce their SFA intake.
PARTICIPANTS AND METHODS
STUDY POPULATION. In 1976, 121,701 female
nurses in the United States 30 to 55 years of
age enrolled in the NHS (9). In 1980, 98,047 of
these women completed an extensive food
frequency questionnaire (FFQ). In 1986,
51,529 U.S. men, 40 to 75 years of age, were
enrolled in the HPFS and returned question-
naires about diet and medical history (10).
Participants from both cohorts provided in-
formation on diet and lifestyle factors, med-
ical history, and newly diagnosed diseases through
self-administered mailed questionnaires at baseline
and every 2 to 4 years thereafter.
For the present analysis, we excluded women and
men (n ¼ 7,615) with implausible FFQ data (<800 or
>4,200 kcal/day for men, <600 or >3,500 kcal/day
for women, or >70 food items missing). We also
excluded participants with previously diagnosed
cancer (n ¼ 5,676), cardiovascular disease (n ¼ 5,609),
or diabetes (n ¼ 3,137) at baseline, or loss of follow-up
after baseline (n ¼ 3). The ﬁnal analysis sample size
was 84,628 women and 42,908 men.
The study protocol was approved by the institu-
tional review boards of Brigham and Women’s Hos-
pital and the Harvard T.H. Chan School of Public
Health. Return of the self-administered question-
naires was considered informed consent.
ASCERTAINMENT OF CHD. We included nonfatal MI
and CHD death as our primary endpoint of total CHD,
which was identiﬁed primarily through a review of
medical records, as previously described (11). Partic-
ipants (or next of kin for deceased participants)
reporting a primary endpoint were asked for permis-
sion to have their medical records reviewed by phy-
sicians who were blinded to the participant’s risk
factor status. MI was conﬁrmed if the World Health
Organization criteria were met (12). MIs that required
hospital admission and for which conﬁrmatory in-
formation was obtained by phone interview or letter,
but for which no medical records were available, were
classiﬁed as probable. We included all conﬁrmed and
probable cases because results were similar in both
previous (9) and present analyses when probable
cases were excluded.
Deaths were identiﬁed by reports from next of kin,
the U.S. postal system, or using certiﬁcates obtained
from state vital statistics departments and the Na-
tional Death Index. Follow-up for deaths was >98%
complete (13). Cases of fatal CHD speciﬁcally were
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was listed as the cause of death on the death certiﬁcate
or if it was listed as an underlying cause of death
and if evidence of previous CHD was available (9,13).
DIETARY ASSESSMENT. NHS participants completed
an FFQ ﬁrst in 1980, and again in 1984, 1986, 1990,
1994, 1998, 2002, and 2006. In the HPFS, we assessed
dietary information using the FFQ, administered every
4 years from 1986 to 2006. Participantswere asked how
often, on average, they had consumed speciﬁc foods
during the past year. Serving sizes were speciﬁed for
each food in the FFQ. The questionnaire had 9 possible
responses, ranging from never or <1 time per month
to$6 times per day. Participants were asked to specify
the types of fat or oil used for frying and baking, at the
table, and the type, if any, of margarine usually used.
Daily intake of fat and fatty acids was calculated by
multiplying the frequency of consumption of each
food item by its nutrient content and summing the
nutrient contributions of all foods on the basis of U.S.
Department of Agriculture food composition data (14),
taking into account types of margarine and fats used in
cooking and baking. The FFQ provides a reasonably
good estimate of total and speciﬁc types of fat
compared with multiple dietary records; correlation
coefﬁcients between intakes from the 1986 question-
naire and 1986 dietary records were 0.57 for total fat,
0.68 for SFAs, 0.48 for polyunsaturated fatty acids
(PUFAs), and 0.58 for monounsaturated fatty acids
(MUFAs) (15). Correlations between dietary fatty acid
intake assessed by the FFQ and the composition of
fatty acids in adipose tissue were 0.51 for trans fat, 0.37
for PUFAs, and 0.48 for long-chain n-3 fatty acids (16).
In our analysis of carbohydrates, we focused on the
major food sources of carbohydrates, including po-
tatoes, added sugars from beverages and foods, and
grains. These were then classiﬁed into 2 carbohydrate
source categories: 1) carbohydrates from whole grains;
and 2) carbohydrates from reﬁned starches/added
sugars, mainly including foods with relatively high GI
values, such as potatoes, reﬁned grains, and added
sugar from beverages and foods (17). The food list is
detailed in Online Table 1. We did not include carbo-
hydrates from fruits, vegetables, or legumes in our
carbohydrate categories because these foods have
beneﬁts separate from their carbohydrate quality in
terms of glycemic effects, and have previously been
shown to be inversely associated with CHD in our co-
horts (18).
Because dietary intake may affect CHD over an
extended period of time, to best represent long-term
intake, we calculated cumulative average intakes of
nutrients using repeated FFQ data for our primaryanalysis (19). We applied time-varying Cox analysis in
which the average of dietary intake at or before the
beginning of a 4-year interval was used as a predictor
for incident CHD in that 4-year interval. For each
follow-up period, baseline CHD cases were excluded.
For example, for the NHS, 1980 (baseline) intake was
used to assess the risk of CHD in the 1980 to 1984
follow-up period. The average of 1980 and 1984 in-
takes was used to assess the risk of CHD in the 1984 to
1986 follow-up period, and the average of 1980, 1984,
and 1986 intakes was used to assess the risk of CHD in
the 1986 to 1990 follow-up period, and so on. Thus,
we maintained a strictly prospective analysis in
assessing the association between a cumulative di-
etary exposure and CHD.
STATISTICAL ANALYSIS. To describe and visualize
changes in dietary habits over time, we assessed 2- to
4-year changes in energy intake from different fatty
acids and carbohydrate sources according to deciles
of 2- to 4-year changes in SFAs as a percentage of
energy intake, using generalized linear models with
repeated-measures analysis with adjustment for age.
Only 1984 to 1986 changes in the NHS were 2-year
changes; all other changes were 4-year changes. For
the change analyses, individuals without consecu-
tively completed FFQs were excluded. Changes in
energy intake from different fatty acids and carbo-
hydrate sources were evaluated as continuous vari-
ables and were censored at the 0.5th and 99.5th
percentiles to minimize the inﬂuence of outliers.
For prospective risk analyses of dietary factors on
CHD, individuals contributed person-time from the
return of the baseline questionnaire (1980 for the
NHS; 1986 for the HPFS) until the date of diagnosis of
CHD, death, loss to follow-up, or the end of the
follow-up period (June 30, 2010 for the NHS; January
30, 2010 for the HPFS), whichever came ﬁrst.
Participants were divided into quintile categories
of intake according to their nutrient intakes. We used
multivariable Cox proportional hazards models to
estimate hazard ratios (HRs) and 95% conﬁdence in-
tervals (CIs) comparing participants in a given quin-
tile category of nutrient intake with those in the
lowest quintile. To quantify a linear trend, we con-
ducted a Wald test for linear trend by assigning the
median intake within each quintile and modeling this
variable continuously.
In the multivariable-adjusted model, we adjusted
for known risk factors for CHD, including body
mass index (<20.9, 21 to 24.9, 25 to 29.9, 30 to 31.9,
and $32 kg/m2); family history of diabetes (yes
or no) and MI (yes or no); menopausal status
(pre- or post-menopausal) and hormone therapy use
TABLE 1 Baseline Characteristics of Men and Women Across Quintile Categories of SFA Intake as a Percentage of Total Energy Intake
SFA Intake
NHS, 1980 HPFS, 1986
Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5
SFAs, median %E 9.6 11.3 12.6 14.1 16.9 7.4 9.2 10.4 11.6 13.6
Age, yrs 47.7 46.6 46.3 46.0 45.8 54.2 53.6 53.0 52.6 52.5
BMI, kg/m2 23.8 24.1 24.2 24.3 24.4 24.6 25.2 25.4 25.7 26.0
Moderate/vigorous physical activity, h/week 4.3 4.0 4.1 4.0 3.8 3.9 3.2 2.8 2.6 2.2
Current smoking, % 27 28 26 27 30 6 7 9 10 14
Pre-menopausal, % 55 56 56 56 57 — — — — —
Multivitamin use, % 38 36 36 34 32 69 65 63 61 58
Regular aspirin use, % 43 46 47 48 47 26 27 27 27 26
Alcohol, g/day 9.4 8.2 7.6 6.9 5.4 14.6 13.6 12.3 10.7 8.7
Dietary cholesterol, mg/day 235 269 286 310 363 216 263 290 318 367
Hypercholesterolemia, % 7 6 5 5 4 17 12 10 9 7
Hypertension, % 17 17 15 15 15 21 20 20 19 18
Family history of diabetes, % 27 28 27 27 28 20 20 19 21 21
Family history of MI, % 19 20 19 19 19 36 33 31 32 30
Total energy, kcal/day 1,642 1,708 1,748 1,778 1,761 1,886 1,928 1,997 2,032 2,069
Nutrient intake, %E
Protein 18.4 18.5 18.7 18.8 19.4 18.2 18.4 18.4 18.5 18.8
Total fatty acids 25.2 30.5 33.4 36.6 43.9 23.4 28.6 31.3 33.8 38.2
MUFAs 9.8 12.1 13.4 15.0 18.3 8.7 10.9 12.0 13.0 14.6
PUFAs 4.5 5.0 5.2 5.4 5.4 5.4 5.9 6.0 6.1 6.0
Trans fat 1.6 2.0 2.1 2.2 2.4 0.8 1.1 1.3 1.4 1.5
Total carbohydrates 51.3 46.8 44.2 41.2 34.2 55.1 49.8 47.5 45.3 41.3
Carbohydrates from whole grains 1.20 1.14 1.05 0.99 0.72 5.2 3.6 3.0 2.5 2.0
Carbohydrates from reﬁned starches/added sugars 23.9 22.8 21.8 20.8 17.7 23.3 23.6 23.8 23.8 22.6
Total energy intake was based on 1986 data. BMI ¼ body mass index; HPFS ¼ Health Professionals Follow-up Study; MI ¼ myocardial infarction; MUFAs ¼ monounsaturated
fatty acids; NHS ¼ Nurses’ Health Study; PUFAs ¼ polyunsaturated fatty acids; Q ¼ quintile; SFA ¼ saturated fatty acid(s); %E ¼ percentage of energy intake.
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aspirin (yes or no) and multiple vitamins (yes or no);
smoking status (never, former, current: 1 to 14, 15 to
24, or $25 cigarettes/day); physical activity (quin-
tiles); presence of hypertension (yes or no) and hy-
percholesterolemia (yes or no) at baseline; and
alcohol intake (0, 0.1 to 4.9, 5.0 to 9.9, 10.0 to 14.9,
15.0 to 29.9 or $30 g/day for men; for women, the
highest 2 categories were merged into $15 g/day);
energy intake (kcal/day); and percentages of energy
from protein and dietary cholesterol (all in quintiles).
We also simultaneously included the percentages of
energy from all types of fats to estimate the main as-
sociation of each fatty acid. We separately included
both categories of carbohydrate sources to estimate
the main associations of each of the 2 carbohydrate
sources.
When estimating the effect of substituting 1 type
of fat or 1 source of carbohydrate for another, we in-
cluded energy contributions from the 2 nutrient types
as continuous variables in the same multivariable-
adjusted model. The differences in their coefﬁcients
and covariance were used to estimate the HR and 95%
CI of the substitution.Incidence of diabetes, angina, hypertension, coro-
nary artery surgery or angioplasty, and hypercholes-
terolemia during follow-up periods were not included
in multivariable models because these may be con-
sidered intermediate outcomes on the causal pathway
between diet and CHD. However, intermediate di-
agnoses were included in sensitivity analyses. In addi-
tional sensitivity analyses, we stopped updating diet at
the beginning of the interval in which the potential in-
termediate outcome(s) developed in the participant.
Because of differences between the 2 cohorts in sex,
follow-up time, and the questionnaires, all analyses
were performed separately in each cohort to achieve
better control of confounding. To obtain overall esti-
mates for both sexes and to increase statistical power,
the HRs from the age- and multivariable-adjusted
models from the 2 cohorts were combined with
the use of a ﬁxed-effects inverse variance-weighted
meta-analysis because no signiﬁcant heterogeneity
between the cohorts was observed. Data were
analyzed using a commercially available software
program (SAS, version 9.2, SAS Institute, Inc., Cary,
North Carolina), and statistical signiﬁcance was set at
a 2-tailed p value <0.05.
TABLE 2 Hazard Ratios (95% Conﬁdence Intervals) of Coronary Heart Disease by Intake of Fatty Acids as Percentages of Total Energy Intake
Quintile Categories of Fat Intake as a Percentage of Total Energy Intake
p Trend1 2 3 4 5
Total fatty acids
NHS
Median, %E 27.6 31.7 34.5 37.6 42.7
No. of cases 808 735 676 698 575
Age-adjusted 1 (Ref.) 1.02 (0.92–1.13) 1.05 (0.94–1.16) 1.21 (1.10–1.35) 1.31 (1.17–1.46) <0.0001
Multivariable* 1 (Ref.) 0.94 (0.85–1.04) 0.89 (0.80–0.99) 0.94 (0.84–1.05) 0.87 (0.76–0.99) 0.06
HPFS
Median, %E 24.1 28.5 31.4 34.2 38.3
No. of cases 833 800 819 878 845
Age-adjusted 1 (Ref.) 1.00 (0.91–1.10) 1.06 (0.96–1.17) 1.19 (1.08–1.31) 1.20 (1.09–1.32) <0.0001
Multivariable* 1 (Ref.) 0.94 (0.85–1.04) 0.94 (0.84–1.04) 0.99 (0.89–1.10) 0.89 (0.79–1.00) 0.16
Pooled
Multivariable* 1 (Ref.) 0.94 (0.87–1.01) 0.91 (0.85–0.99) 0.97 (0.89–1.04) 0.88 (0.8–0.96) 0.02
SFA
NHS
Median, %E 9.6 11.3 12.6 14.1 16.9
No. of cases 791 754 711 649 587
Age-adjusted 1 (Ref.) 1.10 (1.00–1.22) 1.18 (1.07–1.31) 1.28 (1.15–1.42) 1.54 (1.38–1.73) <0.0001
Multivariable* 1 (Ref.) 0.96 (0.86–1.08) 0.95 (0.83–1.09) 0.94 (0.81–1.09) 1.01 (0.84–1.22) 0.73
HPFS
Median, %E 7.4 9.2 10.4 11.6 13.6
No. of cases 808 815 835 870 847
Age-adjusted 1 (Ref.) 1.07 (0.97–1.18) 1.16 (1.05–1.28) 1.26 (1.15–1.39) 1.32 (1.19–1.45) <0.0001
Multivariable* 1 (Ref.) 0.95 (0.86–1.08) 0.96 (0.85–1.10) 0.95 (0.82–1.10) 0.87 (0.74–1.02) 0.16
Pooled
Multivariable* 1 (Ref.) 0.96 (0.89–1.04) 0.96 (0.87–1.05) 0.95 (0.85–1.05) 0.93 (0.82–1.05) 0.46
Trans fat
NHS
Median, %E 1.1 1.5 1.7 2.0 2.6
No. of cases 726 771 748 683 564
Age-adjusted 1 (Ref.) 1.17 (1.06–1.30) 1.26 (1.14–1.40) 1.31 (1.17–1.45) 1.38 (1.23–1.56) <0.0001
Multivariable* 1 (Ref.) 1.08 (0.97–1.21) 1.13 (1.00–1.28) 1.15 (1.00–1.31) 1.20 (1.02–1.40) 0.04
HPFS
Median, %E 0.7 1.0 1.3 1.5 1.9
No. of cases 705 823 877 874 896
Age-adjusted 1 (Ref.) 1.20 (1.08–1.32) 1.26 (1.14–1.39) 1.31 (1.18–1.44) 1.39 (1.25–1.53) <0.0001
Multivariable* 1 (Ref.) 1.18 (1.06–1.32) 1.21 (1.07–1.36) 1.22 (1.07–1.38) 1.21 (1.06–1.38) 0.03
Pooled
Multivariable* 1 (Ref.) 1.13 (1.05–1.22) 1.17 (1.08–1.27) 1.18 (1.08–1.30) 1.20 (1.09–1.32) 0.002
PUFA
NHS
Median, %E 3.9 4.9 5.6 6.3 7.4
No. of cases 763 749 650 726 604
Age-adjusted 1 (Ref.) 0.91 (0.82–1.01) 0.80 (0.72–0.89) 0.92 (0.83–1.03) 0.83 (0.75–0.93) 0.003
Multivariable* 1 (Ref.) 0.91 (0.82–1.01) 0.78 (0.70–0.88) 0.88 (0.78–0.99) 0.76 (0.67–0.87) 0.0003
HPFS
Median, %E 4.4 5.2 5.8 6.4 7.5
No. of cases 886 893 799 831 766
Age-adjusted 1 (Ref.) 1.02 (0.93–1.12) 0.93 (0.84–1.02) 0.98 (0.89–1.08) 0.92 (0.84–1.02) 0.07
Multivariable* 1 (Ref.) 1.00 (0.91–1.10) 0.90 (0.81–1.00) 0.92 (0.83–1.03) 0.83 (0.74–0.94) 0.001
Pooled
Multivariable* 1 (Ref.) 0.96 (0.89–1.03) 0.85 (0.78–0.92) 0.90 (0.84–0.98) 0.80 (0.73–0.88) <0.0001
Continued on the next page
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TABLE 2 Continued
Quintile Categories of Fat Intake as a Percentage of Total Energy Intake
p Trend1 2 3 4 5
MUFAs
NHS
Median, %E 10.4 12.1 13.4 14.8 17.3
No. of cases 788 747 744 669 544
Age-adjusted 1 (Ref.) 1.06 (0.96–1.18) 1.17 (1.06–1.29) 1.18 (1.06–1.31) 1.27 (1.13–1.42) <0.0001
Multivariable* 1 (Ref.) 1.01 (0.90–1.14) 1.05 (0.91–1.21) 0.97 (0.83–1.15) 0.90 (0.74–1.09) 0.22
HPFS
Median, %E 9.0 10.9 12.1 13.3 15.1
No. of cases 810 811 832 833 889
Age-adjusted 1 (Ref.) 1.02 (0.93–1.13) 1.09 (0.99–1.20) 1.12 (1.02–1.23) 1.24 (1.13–1.36) <0.0001
Multivariable* 1 (Ref.) 0.97 (0.86–1.09) 1.01 (0.88–1.15) 1.00 (0.86–1.17) 1.08 (0.91–1.29) 0.33
Pooled
Multivariable* 1 (Ref.) 0.99 (0.91–1.08) 1.03 (0.93–1.13) 0.99 (0.89–1.11) 1.00 (0.87–1.13) 0.86
*The multivariable model was adjusted for total energy intake, the energy contribution from protein, cholesterol intake, alcohol intake, smoking status, body mass index, physical activity, use
of vitamins and aspirin, family history of MI and diabetes, and presence of baseline hypercholesterolemia and hypertension. The model was also adjusted for dietary intake of fruits and
vegetables. The speciﬁc fat models were adjusted for the percentage of energy from all fat types simultaneously. Multivariable models thus represent the effect of substituting a percentage of
energy from total fat or the speciﬁc fat type for an equivalent percentage of energy from total carbohydrates.
Ref. ¼ reference group; other abbreviations as in Table 1.
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PARTICIPANT CHARACTERISTICS. We documented
7,667 cases of CHD (4,931 nonfatal MIs and 2,736 CHD
deaths) over 30 years of follow-up in the NHS and
24 years of follow-up in the HPFS. At baseline (Table 1),
men and women with a high intake of SFAs as a per-
centage of energy were slightly younger, had a higher
body mass index, had a lower prevalence of physical
activity and multivitamin use, and consumed more
cholesterol. Participants with higher energy intake
from SFAs also tended to have higher energy
intake from MUFAs and trans fats and lower energy
intake from carbohydrates (Table 1). Carbohydrates
from whole grains contributed 0.7% to 5.2% of
energy, whereas carbohydrates from reﬁned starches/
added sugars contributed 17.7% to 23.9% of energy.
The percentage of energy from carbohydrates from
whole grains was strongly negatively associated
with intake of SFAs, but the energy contribution
from carbohydrates from reﬁned starches/add sugars
was minimally associated with energy from SFAs
(Table 1).
CHANGES IN ENERGY INTAKE FROM DIFFERENT
FATS AND CARBOHYDRATE SOURCES. Mean 2- to
4-year changes in energy intake from SFAs were posi-
tively associated with changes in energy intake from
MUFAs and negatively associated with changes in en-
ergy intake from carbohydrates from reﬁned starches/
added sugars. Associations were much weaker be-
tween changes in energy intake fromSFAs and changesin energy intake from PUFAs or carbohydrates from
whole grains (Online Figure 1). In other words, partic-
ipants generally replaced calories derived from SFAs
with calories from low-quality carbohydrates rather
than with calories from PUFAs or high-quality
carbohydrates.
MAIN ASSOCIATIONS OF DIFFERENT TYPES OF
FATS AND SOURCES OF CARBOHYDRATES ON RISK
OF CHD. Intakes of SFAs, MUFAs, PUFAs, and trans
fats were each signiﬁcantly associated with a risk of
CHD in age-adjusted analyses (Table 2). When we
incorporated all types of fat into the same model, so
that the HRs represented replacing energy from total
carbohydrates with the same percentage of energy
from each type of fat, higher PUFA intake was as-
sociated with a lower risk of CHD (for highest vs.
lowest quintiles, HR: 0.80, 95% CI: 0.73 to 0.88;
p trend <0.0001), and trans fat intake was signiﬁ-
cantly associated with an increased risk of CHD (HR:
1.20, 95% CI: 1.09 to 1.32; p trend ¼ 0.002). Neither
SFAs nor MUFAs were associated with CHD in multi-
variable models when they were modeled as re-
placements for total carbohydrates.
In analyses of different sources of carbohydrates,
the risk of CHD was signiﬁcantly lower with higher
consumption of energy from carbohydrates from
whole grains (for highest vs. lowest quintiles, HR: 0.90,
95% CI: 0.83 to 0.98; p trend ¼ 0.003), and signiﬁ-
cantly higher with increasing consumption of car-
bohydrates from reﬁned starches/added sugars
(HR: 1.10, 95% CI: 1.00 to 1.21; p trend ¼ 0.04) (Table 3).
TABLE 3 Hazard Ratios (95% Conﬁdence Intervals) of Coronary Heart Disease by Intake of Carbohydrates of Varying Quality as Percentages of Total Energy Intake
Quintile Categories of Carbohydrate Intake as a Percentage of Total Energy Intake
p Trend1 2 3 4 5
Total carbohydrates
NHS
Median, %E 34.7 41.7 45.8 49.4 54.5
No. of cases 560 647 705 740 840
Age-adjusted 1 (Ref.) 0.94 (0.84–1.05) 0.90 (0.81–1.01) 0.85 (0.76–0.96) 0.84 (0.75–0.94) 0.0009
Multivariable* 1 (Ref.) 1.02 (0.90–1.14) 1.03 (0.91–1.17) 1.03 (0.90–1.17) 1.09 (0.94–1.25) 0.26
HPFS
Median, %E 38.7 44.6 48.5 52.3 58.1
No. of cases 818 780 848 857 877
Age-adjusted 1 (Ref.) 0.93 (0.84–1.02) 0.95 (0.86–1.05) 0.91 (0.83–1.00) 0.88 (0.80–0.97) 0.009
Multivariable* 1 (Ref.) 0.98 (0.88–1.08) 1.02 (0.92–1.14) 0.99 (0.89–1.11) 1.00 (0.88–1.14) 0.92
Pooled




Median, %E 14.8 19.4 22.5 25.5 30.3
No. of cases 594 683 712 762 741
Age-adjusted 1 (Ref.) 1.00 (0.89–1.11) 1.03 (0.92–1.15) 1.14 (1.02–1.28) 1.24 (1.11–1.39) <0.0001
Multivariable* 1 (Ref.) 1.01 (0.90–1.14) 1.02 (0.90–1.15) 1.10 (0.96–1.25) 1.10 (0.95–1.28) 0.15
HPFS
Median, %E 16.7 20.9 23.8 26.8 31.6
No. of cases 849 836 833 824 833
Age-adjusted 1 (Ref.) 1.00 (0.91–1.10) 1.04 (0.95–1.15) 1.07 (0.97–1.18) 1.21 (1.10–1.33) <0.0001
Multivariable* 1 (Ref.) 1.02 (0.93–1.13) 1.04 (0.94–1.16) 1.04 (0.93–1.16) 1.10 (0.97–1.25) 0.15
Pooled
Multivariable* 1 (Ref.) 1.02 (0.95–1.10) 1.03 (0.95–1.12) 1.06 (0.98–1.16) 1.10 (1.00–1.21) 0.04
Carbohydrates from whole grains
NHS
Median, %E 0.4 1.0 1.8 2.8 4.6
No. of cases 598 731 680 715 768
Age-adjusted 1 (Ref.) 0.95 (0.85–1.06) 0.74 (0.66–0.83) 0.67 (0.60–0.76) 0.62 (0.55–0.69) <0.0001
Multivariable* 1 (Ref.) 1.05 (0.94–1.18) 0.90 (0.80–1.01) 0.90 (0.79–1.02) 0.92 (0.81–1.05) 0.08
HPFS
Median, %E 0.8 2.0 3.1 4.4 7.0
No. of cases 895 868 820 840 752
Age-adjusted 1 (Ref.) 0.94 (0.85–1.03) 0.82 (0.74–0.90) 0.80 (0.73–0.88) 0.69 (0.63–0.76) <0.0001
Multivariable* 1 (Ref.) 1.03 (0.93–1.13) 0.96 (0.87–1.07) 0.99 (0.90–1.10) 0.88 (0.79–0.99) 0.01
Pooled
Multivariable* 1 (Ref.) 1.04 (0.96–1.11) 0.94 (0.87–1.01) 0.95 (0.88–1.03) 0.90 (0.83–0.98) 0.003
*The multivariable model was adjusted for total energy intake, the energy contribution from protein, cholesterol intake, alcohol intake, smoking status, body mass index, physical activity, use of vitamins and
aspirin, family history of MI and diabetes, and presence of baseline hypercholesterolemia and hypertension. Except for total carbohydrate models, models were also further adjusted for the percentage of
energy from carbohydrates from whole grains, from reﬁned starches/added sugars, and from other foods simultaneously. Multivariable models thus represent the effect of substituting a percentage of
energy from total carbohydrates or the speciﬁc carbohydrate type for an equivalent percentage of energy from total fat.
Abbreviations as in Tables 1 and 2.
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1544SUBSTITUTION ANALYSES. The associations of
various isocaloric dietary substitutions with the risk
of CHD are presented in the Central Illustration.
Isocaloric dietary substitutions of SFAs by trans fats
or carbohydrates from reﬁned starches/added sugars
were not associated with a risk of CHD (p > 0.1 for
both). Replacing 5% of energy from SFAs with 5% of
energy from PUFAs was associated with a 25%
lower risk of CHD (HR: 0.75, 95% CI: 0.67 to 0.84;p < 0.0001). Similarly, replacing 5% of energy from
SFAs with 5% of energy from MUFAs or from car-
bohydrates from whole grains was associated with
signiﬁcantly lower risk of CHD (MUFAs: HR: 0.85,
95% CI: 0.74 to 0.97; p ¼ 0.02; carbohydrates
from whole grains: HR: 0.91, 95% CI: 0.85 to
0.98; p ¼ 0.01). The results were consistent in the
NHS and HPFS (Online Table 2, Online Figure 2).
Replacement of 5% of energy from SFAs with 5% of
CENTRAL ILLUSTRATION Fat, Carbohydrates, and Heart Disease: Estimated Percentage of Changes in the Risk of
Coronary Heart Disease Associated With Isocaloric Substitutions of 1 Dietary Component for Another
Li, Y. et al. J Am Coll Cardiol. 2015; 66(14):1538–48.
Changes in risk are derived from hazard ratios and represented as solid bars; I bars represent 95% conﬁdence intervals. The multivariable model was adjusted for total
energy intake, the energy contribution from protein, cholesterol intake, alcohol intake, smoking status, body mass index, physical activity, use of vitamins and aspirin,
family history of myocardial infarction and diabetes, and presence of baseline hypercholesterolemia and hypertension. MUFA ¼ monounsaturated fatty acid; PUFA ¼
polyunsaturated fatty acid; SFA ¼ saturated fatty acid.
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1545energy from unsaturated fats (MUFAs þ PUFAs) was
associated with 17% lower risk of CHD (HR: 0.83,
95% CI: 0.75 to 0.91; p ¼ 0.0001).
Isocaloric (5%) dietary substitutions of carbohy-
drates from reﬁned starches/added sugars with
PUFAs or with carbohydrates from whole grains were
also signiﬁcantly associated with a lower risk of CHD
(PUFAs, HR: 0.78, 95% CI: 0.71 to 0.85; p < 0.0001;
carbohydrates from whole grains, HR: 0.89, 95% CI:
0.84 to 0.94; p < 0.0001) (Central Illustration).
Replacing carbohydrates from reﬁned starches/added
sugars with SAFs was not signiﬁcantly associated
with CHD risk.
SENSITIVITY ANALYSES. In sensitivity analyses
with further adjustment for potential intermediate
outcomes (hypercholesterolemia, diabetes, angina,hypertension, coronary artery surgery, or angio-
plasty), isocaloric (5%) dietary substitutions of SFAs
with PUFAs, MUFAs, or carbohydrates from whole
grains resulted in 28%, 20%, and 11% lower risk of
CHD, respectively (all p values <0.01). In sensitivity
analyses that stopped updating dietary intake after
the diagnosis of potential intermediate outcomes, the
isocaloric (5%) dietary substitutions of SFAs with
PUFAs, MUFAs, or carbohydrates from whole grains
resulted in 29%, 16%, and 23% lower risk of CHD,
respectively (all p values <0.01).
DISCUSSION
In 2 large, independent prospective cohorts of
U.S. men and women, we found that replacing intake
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1546of energy from SFAs with energy from MUFAs,
PUFAs, or carbohydrates from whole grains was
associated with a lower risk of CHD. In addition,
isocaloric substitution of carbohydrates from reﬁned
starches/added sugars with carbohydrates from
whole grains or with energy from PUFAs was also
associated with a lower risk of CHD. Our ﬁndings
provide epidemiological evidence of the current di-
etary guidelines, which recommend both “replacing
saturated fatty acids with monounsaturated and
polyunsaturated fatty acids” and “replacing reﬁned
grains with whole grains” (20).
A large body of evidence indicates that higher
intake of most dietary SFAs increases blood levels
of low-density lipoprotein cholesterol and the low-
density lipoprotein to high-density lipoprotein ra-
tio (21), both of which are associated with a higher
risk of CHD (22). A reduction in SFA intake has
therefore been at the heart of most dietary recom-
mendations, with the objective of reducing the risk
of cardiovascular diseases. Recently, this hypothesis
was challenged by studies that failed to ﬁnd an
association between SFAs and CHD (1,2). However,
in these studies, the replacement nutrient was not
speciﬁed, although by default, most of the other
calories in almost all diets would have been carbo-
hydrates, primarily from reﬁned grains and added
sugars. Notably, in our own cohorts, we also
observed the less healthful replacement to be the
norm.
In clinical trials, replacement of SFAs with re-
ﬁned carbohydrates has been associated with lower
high-density lipoprotein cholesterol and higher tri-
glycerides (21). The fact that predominantly low-
quality carbohydrates, such as reﬁned grains and
added sugars, have served as the primary isocaloric
replacements of saturated fats in previous analyses,
likely explains the previous null associations between
SFAs and CHD. The importance of the source of
carbohydrates was also suggested by a previous
analysis from Denmark that was stratiﬁed according
to the overall dietary GI (7). In that study, replacing
SFAs with carbohydrates was associated with a
higher risk of MI when the dietary GI was high;
however, when the dietary GI was low, replacing
SFAs with carbohydrates was associated with a
nonsigniﬁcantly lower risk of MI. Our study provides
further evidence that the macronutrient substituted
for SFAs is critically important: replacing SFAs with
high-quality carbohydrates such as whole grains may
decrease the risk of CHD, whereas replacing SFAs
with low-quality carbohydrates, such as white bread,
white rice, or potatoes, is not beneﬁcial for CHD
prevention.There is strong scientiﬁc evidence of a decrease in
the risk of CHD when SFAs are replaced with PUFAs. A
pooled analysis of 11 prospective cohort studies
indicated that replacing 5% of energy from SFAs with
energy from PUFAs was associated with a 13% lower
risk of CHD (2). This estimate was conﬁrmed by a
meta-analysis of 8 clinical trials that used PUFA
consumption as a replacement for SFAs ﬁnding that
each 1% of energy from PUFAs replacing SFAs
reduced the occurrence of CHD events by 2% (23).
Substitution of SFAs by PUFAs also reduces the total-
to-HDL cholesterol ratio, compared with replacing
SFAs with carbohydrates (23).
Our ﬁndings suggest that PUFAs, such as those
from vegetable oils, nuts, and seeds, should have an
expanded role as a replacement for SFAs. However,
our data and data from national surveys suggest that,
when decreasing SFA intake, most people appear
to increase the intake of low-quality carbohydrates,
such as reﬁned starches and/or added sugars, ra-
ther than increase the intake of unsaturated fats.
The 2010 American Dietary Guidelines recommend
“consuming at least half of all grains as whole
grains” (20). Although whole-grain consumption
has increased in the United States in recent de-
cades (24), overall intake is still quite low (around 1
ounce-equivalent of whole grains per day); <5% of
people in the United States consume the minimum
recommended amount of whole grains, which, for
most, is about 3 ounce-equivalents per day (20).
These consumption patterns suggest that there
is substantial room for improvement in the Amer-
ican diet when it comes to intake of PUFAs
and whole grains as meaningful replacements for
SFAs.
Because MUFAs tend to share the same food
sources as SFAs (e.g., meats and dairy), the estimated
association between MUFAs and CHD risk in most
epidemiological studies in the United States is likely
to be confounded by these food sources. In our study,
replacing SFAs with MUFAs was associated with a
lower CHD risk, suggesting that there are healthful
beneﬁts to replacing food sources of saturated fats
with plant sources of MUFAs, such as vegetables oils
(e.g., olive oil and canola oil), nuts, and seeds. The
apparent beneﬁt that we observed for MUFAs is
consistent with their effects on low- and high-density
lipoprotein cholesterol, which are similar to those for
PUFAs (21,23). In the PREDIMED (Prevención con
Dieta Mediterránea) trial, the intervention groups
consuming a Mediterranean diet supplemented with
extra-virgin olive oil or mixed nuts experienced a
30% lower risk of cardiovascular disease compared
with the control group (25).
PERSPECTIVES
COMPETENCY IN PATIENT CARE: Guiding individuals
toward healthy dietary choices as they work to reduce their
saturated fat intake should specify their replacement with
PUFAs or MUFAs or high-quality carbohydrates.
TRANSLATIONAL OUTLOOK: Further individual-level and
population-level research is needed to optimize dietary scoring
schemes and optimal substitution ratios to replace saturated
fats with unsaturated fats, carbohydrates, and other food
components.
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1547STUDY LIMITATIONS AND STRENGTHS. Given its
observational nature, our study cannot prove causal-
ity. Similar to other observational studies, it is difﬁ-
cult to rule out residual confounding, despite careful
control for potential confounders in the analyses.
However, our results were generally consistent with
those from randomized clinical trials on diet and
blood lipids and cardiovascular risk. In addition,
measurement errors are inevitable in estimates of
food and nutrient intakes. However, our adjustment
for energy intake and use of prospectively collected,
cumulatively averaged intake reduced the magnitude
of measurement errors (26). In addition, we could not
make ﬁner distinctions between subtypes of CHD
(e.g., ST-segment elevation MI), which would require
electrocardiographic data that were not collected
in the cohorts. Such subtypes may be relevant to
the present hypothesis, and future research in this
area is warranted. Although our cohorts beneﬁtted
from their homogeneity in terms of internal validity,
the associations that we observed in this population
may not be generalizable to more diverse pop-
ulations. The strengths of the present study include
its large sample size, high rates of long-term follow-
up, and detailed, repeated assessments of diet and
lifestyle. The consistent ﬁndings across 2 cohorts
demonstrate the robustness of the results. All
participants were health professionals, minimizing
potential confounding by educational attainment or
differential access to health care. In addition, the
FFQs used in these studies were validated against
multiple weighed diet records and biochemical
markers.CONCLUSIONS
Our data suggest that replacing SFAs with PUFAs,
MUFAs, or carbohydrates from whole grains is associ-
ated with a lower CHD risk. We further observed that
replacing carbohydrates from reﬁned starches/added
sugars with PUFAs or carbohydrates fromwhole grains
was associated with a lower risk of CHD. Our ob-
servations, together with evidence from previous
studies, indicate that evidence-based, population-
level and individual-level recommendations to reduce
SFA consumption should specify replacing SFAs with
unsaturated fats and/or high-quality carbohydrates.
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